Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma [1]

International Journal of Hematology

Volumn 83, Issue 4, 2006, Pages 363-365

  Ikeda, Jun Ichiro ^a   Morii, Eiichi ^a   Tomita, Yasuhiko ^a   Xu, Jing Xian ^a   Kimura, Hayato ^a   Kohara, Masaharu ^a   Hoshida, Yoshihiko ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PIRARUBICIN; PREDNISOLONE; RITUXIMAB; STEROID; VINCRISTINE;

CELL TRANSFORMATION; CLONAL VARIATION; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; LASER CAPTURE MICRODISSECTION; LETTER; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RHEUMATOID ARTHRITIS; SOMATIC MUTATION;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; METHOTREXATE; MIDDLE AGED;

EID: 33744500996     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05181     Document Type: Letter

References (11)

1. Furst DE, Clements PJ. Immunosuppressives. In: Kippel JH, Dieppe PA, eds. Rheumatology. 2nd ed. London: Mosby: 1998: 3.9.1-3.9.9.
2. Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Lyon: IARC Press; 2001:270-271.
3. Losses IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000;95:1797-1803.
4. Pocock C, Matutes E, Wotherspoon A, Cunningham D, Catovski D. Fludarabine therapy may precipitate large cell transformation in chronic lymphocytic leukemia but not in follicular lymphoma. Blood. 1998;92(suppl 1):429(abstract 1774).
5. Tabuteau S, Giardi R, Fernandes J, et al. Fludarabine (FAMP) and risk of occurrence of Richters syndrome among B-CLL. Blood. 2000;96:295b(abstract 5019).
6. Robak T, Kasznicki M, Bartkowiak J, Kordek R, Wawrzyniak E, Blonski JZ. Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur. Leuk Lymphoma. 2001;42:789-796.
7. Cheson BD, Vena DA, Barrett J, Freidlin B. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol. 1999;17:2454-2460.
8. Robertson LE, Pugh W, O'Brien S, et al. Richter's syndrome: a report on 39 patients. J Clin Oncol. 1993;11:1985-1989.
9. Morrison VA. Transformation to Richter's syndrome or prolymphocytic leukemia (PLL), and other second hematologic malignancies in patients with chronic lymphocytic leukemia (CLL). An Intergroup Study (CALGB 9011). Blood. 1999;94:539a(abstract).
10. Leporrier M, Chevret S, Cazin B, et al. Randomized comparison of fludarabine, CAP, and CHOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 2001;98: 2319-2325.
11. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99:3806-3812.